TherapeuticsMD (TXMD) Other financing activities (2010 - 2023)
TherapeuticsMD's (TXMD) quarterly Other financing activities came in at -$1.1 million in Q3 2023, down 8007.14% YoY from $14000.0 in Q3 2022, and down 110800.0% on a QoQ basis from $1000.0 in Q2 2023.
TherapeuticsMD (TXMD) Other financing activities (2010 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 13 years of Other financing activities data on file, last reported at -$1.1 million in Q3 2023.
- Quarterly Other financing activities fell 8007.14% year-over-year to -$1.1 million in Q3 2023, while the trailing twelve-month figure through Mar 2024 was -$1.1 million (down 200.0% YoY) and the FY2021 annual result came in at $322000.0, down 74.24% from the prior year.
- Other financing activities eased to -$1.1 million in Q3 2023, from $1000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.6 million in Q3 2019 to a low of -$6.5 million in Q4 2019.
- A 5-year average of $112066.7 and a median of $50000.0 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2019 — Other financing activities surged 6005.43% — and 2023, when it sank 8007.14%.
- Tracing TXMD's Other financing activities over 5 years: stood at -$6.5 million in 2019, then surged by 116.57% to $1.1 million in 2020, then plunged by 542.44% to -$4.8 million in 2021, then soared by 99.71% to -$14000.0 in 2022, then sank by 7807.14% to -$1.1 million in 2023.
- The last three Other financing activities figures came in at -$1.1 million (Q3 2023), $1000.0 (Q2 2023), and $1.1 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.11 Mn |
| Sep 30, 2023 | -1.11 Mn |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | -14,000.00 |
| Dec 31, 2022 | -14,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Dec 31, 2021 | -4.80 Mn |
| Dec 31, 2021 | -4.80 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 249,000.00 |
| Jun 30, 2021 | 249,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Sep 30, 2020 | 1.08 Mn |
| Sep 30, 2020 | 1.08 Mn |